• Home
  • NEW DAY MEDICINE
  • 6 (80) 2025
  • 103 -6 (80) 2025 - Yusupova Sh.K., Abdurahmanova R.Kh. - PREVALENCE OF PREDIABETES AND TYPE 2 DIABETES MELLITUS AMONG THE POPULATION OF THE ANDIJAN REGION

103 -6 (80) 2025 - Yusupova Sh.K., Abdurahmanova R.Kh. - PREVALENCE OF PREDIABETES AND TYPE 2 DIABETES MELLITUS AMONG THE POPULATION OF THE ANDIJAN REGION

PREVALENCE OF PREDIABETES AND TYPE 2 DIABETES MELLITUS AMONG THE POPULATION OF THE ANDIJAN REGION

Yusupova Sh.K. - Andijan State Medical Institute

Abdurahmanova R.Kh. - Andijan State Medical Institute

Resume

Prediabetes is a condition characterized by an elevated blood glucose level below the threshold value for diagnosing diabetes, but associated with a higher risk of developing diabetes. Impaired glucose tolerance (IGT) (2-hour glucose 7.8-11.0 mmol/l [140-199 mg/dl]) and impaired fasting glucose (IFG) (fasting glucose 6.1-6.9 mmol/l [110-125 mg/dl]), based on World Health Organization (WHO) criteria, are commonly used to define prediabetes

Key words: prediabetes, incidence, urban, rural

First page

503

Last page

506

For citation:Yusupova Sh.K., Abdurahmanova R.Kh. - PREVALENCE OF PREDIABETES AND TYPE 2 DIABETES MELLITUS AMONG THE POPULATION OF THE ANDIJAN REGION//New Day in Medicine 6(80)2025 503-506 https://newdayworldmedicine.com/en/new_day_medicine/6-80-2025

List of References

  1. Echouffo-Tcheugui J. B., Selvin E. Prediabetes and what it means: the epidemiological evidence //Annual review of public health. – 2021. – Т. 42. – №. 1. – С. 59-77.
  2. Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. //Diabetes. 2009 Apr;58(4):773-95. doi: 10.2337/db09-9028.
  3. Abdul-Ghani M. A., Tripathy D., Defronzo R. A. Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose //Diabetes care. – 2006. – Т. 29. – №. 5. – С. 1130-1139.
  4. Nathan D. M. et al. Impaired fasting glucose and impaired glucose tolerance: implications for care //Diabetes care. – 2007. – Т. 30. – №. 3. – С. 753-759.
  5. Richter B. et al. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia //Cochrane Database of Systematic Reviews. – 2018. – №. 10.
  6. Warren B, Pankow JS, Matsushita K, Punjabi NM, Daya NR, Grams M, Woodward M, Selvin E. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. // Lancet Diabetes Endocrinol. 2017 Jan;5(1):34-42. doi: 10.1016/S2213-8587(16)30321-7.
  7. Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. //BMJ. 2016 Nov 23;355:i5953. doi: 10.1136/bmj.i5953
  8. Howells L, Musaddaq B, McKay AJ, Majeed A. Clinical impact of lifestyle interventions for the prevention of diabetes: an overview of systematic reviews. //BMJ Open. 2016 Dec 21;6(12):e013806. doi: 10.1136/bmjopen-2016-013806
  9. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. //N Engl J Med. 2001 May 3;344(18):1343-50. doi: 10.1056/NEJM200105033441801
  10. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. //Diabetes Care. 1997 Apr;20(4):537-44. doi: 10.2337/diacare.20.4.537.

    file

    download